They identify the most common blind spot for founders as a failure
to
realistically evaluate the market value of future products and
acknowledge competitors.
Fundamental questions that should be asked in evaluating a venture
are whether or not a sufficiently large market exists and if it can
be profitably
served. Unsubstantiated estimates such as ‘we expect to serve x
percent of the $y billion market’ indicate a fundamental lack of
understanding of business development needs. It is not sufficient to
simply assume acquisition
of a proportion of an existing market; a bottom-up analysis is
essential to account for the key actions and costs involved in
acquiring market-share and serving a market.
Many entrepreneurs also fail to account for all existing and
potential competitors or their responses to new market entry. Some
competitors may already serve the target market, but potential
customers may also be using alternative solutions; horse-drawn wagons
were competitors to the first cars. Potential competitors,
represented by future technologies, must also be considered. Even
with a complete inventory of competitors, a common
mistake is to assume that competitors will act rationally.
First Steps
With an understanding of the fundamentals of biotechnology
business
development and a commercial idea, the bioentrepreneur is faced with
the challenge of how to proceed. What should one do first: Write a
business plan? File patents? Assemble a management team? Raise money?
Perform critical proof of principle research? Completing these
critical steps in the correct order is essential for success. Bad
timing can lead to false starts or loss of commercial opportunity.
Technology is first and foremost in biotechnology. The goal of
biotenology